Whole-blood dysregulation of actin-cytoskeleton pathway in adult spinal muscular atrophy patients.
Jennifer J SiranosianFlavia C NeryChristiano R R AlvesBenjamin A SiranosianNicholas J LyonsEric J EichelbergerReid GarnerSalomé Da Silva Duarte LepezAlec J JohnstoneAravind SubramanianKathryn J SwobodaPublished in: Annals of clinical and translational neurology (2020)
Our findings from whole blood and patient-derived fibroblasts suggest SMA type 3 patients have decreased expression of actin cytoskeleton regulators. These observations provide new insights and potential therapeutic targets for SMA patients with longstanding denervation and secondary musculoskeletal pathophysiology.